China NMPA Product Recall - Magnetic Resonance Imaging System

GE Healthcare, through its local entity GE Healthcare Systems Trading Development (Shanghai) Co., Ltd., initiated a voluntary recall of several Magnetic Resonance Imaging (MRI) Systems. The recall was reported to the National Medical Products Administration (NMPA) on August 11, 2015, and publicly announced on September 7, 2015. The core issue stemmed from the omission of specific inspection items, notably radio frequency (RF) power monitor checks, during annual maintenance in certain regions. This deficiency was identified following a recent internal review. The regulatory framework involved the NMPA's oversight of medical device safety.

The recall was strictly confined to products sold in India, with GE Healthcare confirming that no affected MRI systems were sold or imported into China. No injuries were reported as a result of this issue. Required actions involved GE Healthcare conducting the previously omitted inspections on the affected products in India. Furthermore, the NMPA directed all provincial Food and Drug Administrations in China to enhance their supervision and management of similar medical devices, despite the products not being distributed within the Chinese market.